BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,934,447 | -29.5% | 662,555 | -6.4% | 0.00% | 0.0% |
Q2 2023 | $22,596,222 | +2.2% | 707,680 | -2.0% | 0.00% | -33.3% |
Q1 2023 | $22,111,310 | +76156.4% | 722,135 | -2.6% | 0.00% | -25.0% |
Q4 2022 | $28,996 | -99.9% | 741,415 | -1.8% | 0.00% | -20.0% |
Q3 2022 | $35,975,000 | +25.8% | 755,156 | +2.2% | 0.01% | +25.0% |
Q2 2022 | $28,600,000 | -32.8% | 738,860 | -0.5% | 0.00% | -20.0% |
Q1 2022 | $42,555,000 | -27.2% | 742,669 | +1.3% | 0.01% | -28.6% |
Q4 2021 | $58,421,000 | +7.2% | 733,094 | +17.0% | 0.01% | 0.0% |
Q3 2021 | $54,514,000 | -19.4% | 626,512 | +19.2% | 0.01% | -12.5% |
Q2 2021 | $67,668,000 | +138.5% | 525,740 | +48.3% | 0.01% | +100.0% |
Q1 2021 | $28,372,000 | +48.2% | 354,488 | +51.2% | 0.00% | +33.3% |
Q4 2020 | $19,141,000 | +343.7% | 234,458 | +34.3% | 0.00% | +200.0% |
Q3 2020 | $4,314,000 | +276.4% | 174,523 | +326.4% | 0.00% | – |
Q2 2020 | $1,146,000 | +58.5% | 40,929 | +1.8% | 0.00% | – |
Q1 2020 | $723,000 | – | 40,186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |